dicemolecules.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: Sitemap: | ||
Meta Tags
| Title | DICE |
| Description | Developing transformative medicines for autoimmune and inflammatory DICE brings together industry veterans with a passion for immunology and small molecule discovery. We envision a world where convenient oral medicines with biologic-like efficacy are available to patients with chronic |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 99.83.190.102 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
dicemolecules.com Valuation
|
US$1,124
Last updated: 2023-05-12 14:51:23
dicemolecules.com has Semrush global rank of 0. dicemolecules.com has an estimated worth of US$ 1,124, based on its estimated Ads revenue. dicemolecules.com receives approximately 129 unique visitors each day. Its web server is located in United States, with IP address 99.83.190.102. According to SiteAdvisor, dicemolecules.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,124 |
| Daily Ads Revenue | US$1 |
| Monthly Ads Revenue | US$31 |
| Yearly Ads Revenue | US$373 |
| Daily Unique Visitors | 8 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| dicemolecules.com. | A | 3599 | IP: 99.83.190.102 |
| dicemolecules.com. | A | 3599 | IP: 75.2.70.75 |
| dicemolecules.com. | NS | 3600 | NS Record: ns74.domaincontrol.com. |
| dicemolecules.com. | NS | 3600 | NS Record: ns73.domaincontrol.com. |
| dicemolecules.com. | MX | 3600 | MX Record: 0 dicemolecules-com.mail.protection.outlook.com. |
| dicemolecules.com. | TXT | 3600 | TXT Record: ppe-94b9449c9ad08c5dd5f4 |
| dicemolecules.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
| dicemolecules.com. | TXT | 3600 | TXT Record: ZOOM_verify_ypglHNqXTN27_y5wXaGcDw |
| dicemolecules.com. | TXT | 3600 | TXT Record: v=verifydomain MS=1866369 |
HtmlToTextCheckTime:2023-05-12 14:51:23
| About Approach Pipeline Patients Investors Careers Developing transformative medicines for autoimmune and inflammatory diseases Expecting More Out of Medicine We design and develop innovative oral medicines against biologically validated targets in immunology for the treatment of chronic autoimmune and inflammatory diseases. We are developing a growing pipeline of high-impact oral therapeutic candidates. Our lead program targets the IL-17 cytokine for psoriasis and other IL-17 mediated diseases. Our Pipeline DELSCAPE: A New Approach to Immunology Currently available biologics have transformed the inflammatory disease landscape by targeting protein-protein interactions (PPIs) such as the binding of an inflammatory cytokine to its receptor. However, these medicines are not ideally suited for chronic treatment and face multiple challenges, including administration through injections or intravenous infusions and regular patient monitoring. Our DELSCAPE platform is designed to identify |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: openresty Date: Sun, 19 Dec 2021 11:28:05 GMT Content-Type: text/html Content-Length: 166 Connection: keep-alive Location: https://dicemolecules.com/ HTTP/2 301 server: openresty date: Sun, 19 Dec 2021 11:28:06 GMT content-type: text/html content-length: 166 location: https://www.dicemolecules.com/ HTTP/2 301 server: openresty date: Sun, 19 Dec 2021 11:28:06 GMT content-type: text/html content-length: 166 cache-control: private location: https://www.dicetherapeutics.com/ accept-ranges: bytes via: 1.1 varnish x-served-by: cache-iad-kiad7000027-IAD x-cache: MISS x-cache-hits: 0 x-timer: S1639913286.316488,VS0,VE56 x-cluster-name: us-east-1-prod-edge-eks-15 HTTP/2 200 server: openresty date: Sun, 19 Dec 2021 11:28:06 GMT content-type: text/html content-length: 15306 accept-ranges: bytes via: 1.1 varnish age: 3332 x-served-by: cache-iad-kiad7000142-IAD x-cache: HIT x-cache-hits: 1 x-timer: S1639913287.513504,VS0,VE1 vary: Accept-Encoding x-cluster-name: us-east-1-prod-edge-eks-15 |
dicemolecules.com Whois Information
Domain Name: DICEMOLECULES.COM Registry Domain ID: 1834698870_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-11-09T19:25:53Z Creation Date: 2013-11-08T16:44:31Z Registry Expiry Date: 2023-11-08T16:44:31Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS73.DOMAINCONTROL.COM Name Server: NS74.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-23T07:27:59Z <<< |